Why tooth decay may make colon cancer more aggressive, by researchers
0 : views
March 12th, 2019 08:33 AM
Tooth decay may make colon cancer more aggressive, according to a
new study.The findings add to the growing swell of research that show
oral health may be linked to much, much more than just the look and
smell of our teeth.
In the last few years,
research has shown dental plaque is linked to heart health, neurological
disorders, and tumor growth. And now Dr. Yiping Han, a pioneer in this
emerging field, has found another connection: people with bowel cancer
may be harder to treat if they have poor oral health.
Dr. Han, of Columbia University’s College of Dental Medicine, said the
finding helps explain why some cases advance far more quickly than
others. Ultimately, it suggests we may be blinkering our vision by
focusing on the tumor’s mutations alone, rather than other factors.
“Mutations are just part of the story,” Han said. “Other factors,
including microbes, can also play a role.”The research team worked out
how F. nucleatum – a common oral bacteria often implicated in tooth
decay – accelerates the growth of colon cancer.
A third of colorectal cancers are associated with a common oral
bacterium called F. nucleatum. Those cases are often the most
aggressive, but nobody knew why.In a previous study, Dr Han’s research
team discovered that the bacterium makes a molecule called FadA adhesin,
triggering a signaling pathway in colon cells that has been implicated
in several cancers.
They also found that
FadA adhesin only stimulates the growth of cancerous cells, not healthy
cells.Dr Han said: “We needed to find out why F. nucleatum only seemed
to interact with the cancerous cells.”In the new study, the researchers
found in cell cultures that non-cancerous colon cells lack a protein,
called Annexin A1, which stimulates cancer growth.They then confirmed
both in vitro and later in mice that disabling Annexin A1 prevented F.
nucleatum from binding to the cancer cells, slowing their growth.
The researchers also discovered that F. nucleatum increases production
of Annexin A1, attracting more of the bacteria.Han said: “We identified
a positive feedback loop that worsens the cancer’s progression.“We
propose a two-hit model, where genetic mutations are the first hit. F.
nucleatum serves as the second hit, accelerating the cancer signaling
pathway and speeding tumour growth.”
The
researchers then looked at an RNA-sequencing data set, available through
the National Center for Biotechnology Information of 466 patients with
primary colon cancer.
Their findings,
published online in the journal EMBO Reports, showed that patients with
increased Annexin A1 expression had a worse prognosis, regardless of the
cancer grade and stage, age, or sex.The research team is now looking
for ways to develop Annexin A1 as a biomarker for more aggressive
cancers, and as a potential target for developing new treatments for
bowel and other types of cancer.